Journal of Antimicrobial Chemotherapy (2002) 49, 77-85
© 2002 The British Society for Antimicrobial Chemotherapy
Patterns and mechanisms of resistance to ß-lactams and ß-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal
a CIISA, Faculty of Veterinary Medicine, Universidade Técnica de Lisboa, Rua Prof. Cid dos Santos, 1300-477, Lisboa b Antibiotic Resistance Unit, National Institute of Health Dr. Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisboa, Portugal
Little is known about ß-lactam and ß-lactamase inhibitor susceptibilities of uropathogenic Escherichia coli isolates from animals. Seventy-two isolates collected from canine urinary tract infections were studied by disc diffusion and microdilution methods. The mechanisms responsible for amoxicillin resistance were associated with the production of ß-lactamases in 26 (36%) isolates. These ß-lactamases were further characterized by isoelectric focusing (IEF) and PCR, and blaTEM, blaOXA-1, blaSHV and ampC genes were detected. The isolates were highly resistant to amoxicillin and ticarcillin, with MIC90s of 2048 mg/L. The MIC90 of cefalothin was 128 mg/L, but the MIC90s of ceftazidime, ceftriaxone, cefotaxime and aztreonam were lower (0.5, 0.06, 0.25 and 0.5 mg/L, respectively). Fourteen isolates were not inhibited by clavulanate. The mechanisms of resistance to ß-lactams and ß-lactamase inhibitors involved the presence of TEM-1 ß-lactamase in 20 isolates, which had an isoelectric point (pI) of 5.4 and were positive for the presence of the blaTEM gene. Fourteen of these isolates produced TEM-1 ß-lactamase alone, and the other six showed an additional band at pI 9.09.2 on IEF and the ampC gene by PCR, indicating the simultaneous production of AmpC enzyme. IEF showed that one isolate produced AmpC alone and PCR detected the presence of the ampC gene. Three of the 26 ß-lactamases with a pI of 7.6 belonged to the SHV family, which was confirmed by the presence of the blaSHV gene. The remaining two ß-lactamases were OXA-1 focusing at 7.4, and were encoded by the blaOXA-1 gene. Resistance to ß-lactamase inhibitors was mediated mainly by TEM-1 alone (six of 26) or together with AmpC (four of 26), AmpC alone (one of 26), SHV (one of 26) and OXA-1 (two of 26) enzymes. Clear resistance to extended-spectrum cephalosporins, ceftazidime and ceftriaxone (64 mg/L), was found in one isolate. Isolates producing either AmpC or OXA-1 enzymes or producing high levels of TEM-1 ß-lactamases had susceptibility patterns that were difficult to distinguish without IEF and/or amplification of the corresponding specific genes. This work supports the need for antimicrobial resistance surveillance in veterinary medicine.
* Corresponding author. Tel: +35-121-3652800; Fax: +35-121-3652810; E-mail: cferia{at}fmv.utl.pt
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Mendonca, J. Leitao, V. Manageiro, E. Ferreira, the Antimicrobial Resistance Surveillance Program, and M. Canica Spread of Extended-Spectrum {beta}-Lactamase CTX-M-Producing Escherichia coli Clinical Isolates in Community and Nosocomial Environments in Portugal Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1946 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Stegemann, C. A. Passmore, J. Sherington, C. J. Lindeman, G. Papp, D. J. Weigel, and T. L. Skogerboe Antimicrobial Activity and Spectrum of Cefovecin, a New Extended- Spectrum Cephalosporin, against Pathogens Collected from Dogs and Cats in Europe and North America. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, K. M. Townsend, N. D. Hanson, J. M. Bell, H. W. Stokes, K. S. Gobius, S. M. Moss, and D. J. Trott Identification of blaCMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia J. Antimicrob. Chemother., May 1, 2006; 57(5): 840 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mendonca, D. Louro, A. P. Castro, J. Diogo, and M. Canica CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions J. Antimicrob. Chemother., May 1, 2006; 57(5): 1014 - 1016. [Full Text] [PDF] |
||||
![]() |
P. Boerlin, R. Travis, C. L. Gyles, R. Reid-Smith, N. J. Heather Lim, V. Nicholson, S. A. McEwen, R. Friendship, and M. Archambault Antimicrobial Resistance and Virulence Genes of Escherichia coli Isolates from Swine in Ontario Appl. Envir. Microbiol., November 1, 2005; 71(11): 6753 - 6761. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Maynard, S. Bekal, F. Sanschagrin, R. C. Levesque, R. Brousseau, L. Masson, S. Lariviere, and J. Harel Heterogeneity among Virulence and Antimicrobial Resistance Gene Profiles of Extraintestinal Escherichia coli Isolates of Animal and Human Origin J. Clin. Microbiol., December 1, 2004; 42(12): 5444 - 5452. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Trott, L. J. Filippich, J. C. Bensink, M. T. Downs, S. E. McKenzie, K. M. Townsend, S. M. Moss, and J. J.-C. Chin Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli J. Med. Microbiol., May 1, 2004; 53(5): 439 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brinas, M. A. Moreno, M. Zarazaga, C. Porrero, Y. Saenz, M. Garcia, L. Dominguez, and C. Torres Detection of CMY-2, CTX-M-14, and SHV-12 {beta}-Lactamases in Escherichia coli Fecal-Sample Isolates from Healthy Chickens Antimicrob. Agents Chemother., June 1, 2003; 47(6): 2056 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Canica, M. Ferreira, E. Ferreira, and L. Cabral Phenotype and Molecular Characterization of the First Inhibitor-Resistant TEM-Derived {beta}-Lactamase Identified in Portugal Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3688 - 3689. [Full Text] [PDF] |
||||
![]() |
L. Brinas, M. Zarazaga, Y. Saenz, F. Ruiz-Larrea, and C. Torres {beta}-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3156 - 3163. [Abstract] [Full Text] [PDF] |
||||




